{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:58:39Z","timestamp":1790888319719,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04353-5","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:33:52Z","timestamp":1764225232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The relationship between lipid accumulation products and non-alcoholic fatty liver disease among adults in the North of Iran: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Catherine","family":"Behzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Atashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Hafezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Motamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansooreh","family":"Maadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Sobhrakhshankhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Shateri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-2520","authenticated-orcid":false,"given":"Azam","family":"Doustmohammadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"1","key":"4353_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"JP Arab","year":"2018","unstructured":"Arab JP, Arrese M, Trauner M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu Rev Pathol. 2018;13(1):321\u201350.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"4353_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/cld.81","volume":"1","author":"P Puri","year":"2012","unstructured":"Puri P, Sanyal AJ. Nonalcoholic fatty liver disease: definitions, risk factors, and workup. Clin Liver Dis. 2012;1(4):99\u2013103.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"4353_CR3","first-page":"76","volume":"8","author":"R Kumar","year":"2020","unstructured":"Kumar R, Priyadarshi RN, Anand U. Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations. J Clin Transl Hepatol. 2020;8(1):76.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"4353_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1053\/j.gastro.2005.05.041","volume":"129","author":"C Day","year":"2005","unstructured":"Day C. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129(1):375\u20138.","journal-title":"Gastroenterology"},{"issue":"4","key":"4353_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.21327","volume":"44","author":"M Ekstedt","year":"2006","unstructured":"Ekstedt M, Franz\u00e9n LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow\u2010up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865\u201373.","journal-title":"Hepatology"},{"issue":"7","key":"4353_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/gut.2009.205088","volume":"59","author":"VW-S Wong","year":"2010","unstructured":"Wong VW-S, Wong GL-H, Choi PC-L, Chan AW-H, Li MK-P, Chan H-Y, Chim AM-L, Yu J, Sung JJ-Y, Chan HL-Y. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut. 2010;59(7):969\u201374.","journal-title":"Gut"},{"issue":"1","key":"4353_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, Tan DJH, Tang ASP, Tay P, Xiao J. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"4353_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"4353_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2023.06.009","volume":"14","author":"SP Tabaeian","year":"2024","unstructured":"Tabaeian SP, Rezapour A, Azari S, Martini M, Saran M, Behzadifar M, et al. Prevalence of non-alcoholic fatty liver disease in Iran: a systematic review and meta-analysis. J Clin Exp Hepatol. 2024;14(1):101209.","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"4353_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","volume":"141","author":"MR Charlton","year":"2011","unstructured":"Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the united States. Gastroenterology. 2011;141(4):1249\u201353.","journal-title":"Gastroenterology"},{"key":"4353_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11901-016-0294-x","volume":"15","author":"W Siow","year":"2016","unstructured":"Siow W, van der Poorten D, George J. Epidemiological trends in NASH as a cause for liver transplant. Curr Hepatol Rep. 2016;15:67\u201374.","journal-title":"Curr Hepatol Rep"},{"key":"4353_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.csbj.2024.01.007","volume":"23","author":"J Chen","year":"2024","unstructured":"Chen J, Lu RS, Diaz-Canestro C, Song E, Jia X, Liu Y, Wang C, Cheung CK, Panagiotou G, Xu A. Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in obese Chinese. Comput Struct Biotechnol J. 2024;23:791\u2013800.","journal-title":"Comput Struct Biotechnol J"},{"key":"4353_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-017-0206-2","volume":"14","author":"H Dai","year":"2017","unstructured":"Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab. 2017;14:1\u20139.","journal-title":"Nutr Metab"},{"key":"4353_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/17562848211062807","volume":"14","author":"P Decharatanachart","year":"2021","unstructured":"Decharatanachart P, Chaiteerakij R, Tiyarattanachai T, Treeprasertsuk S. Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis. Ther Adv Gastroenterol. 2021;14:17562848211062807.","journal-title":"Ther Adv Gastroenterol"},{"issue":"5","key":"4353_CR15","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264\u201381. e1264.","journal-title":"Gastroenterology"},{"issue":"11","key":"4353_CR16","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","volume":"25","author":"J-H Zhou","year":"2019","unstructured":"Zhou J-H, Cai J-J, She Z-G, Li H-L. Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice. World J Gastroenterol. 2019;25(11):1307.","journal-title":"World J Gastroenterol"},{"key":"4353_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-021-01561-2","volume":"20","author":"G Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20:1\u201314.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"4353_CR18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s40200-022-01114-z","volume":"21","author":"S Khanmohammadi","year":"2022","unstructured":"Khanmohammadi S, Tavolinejad H, Aminorroaya A, Rezaie Y, Ashraf H, Vasheghani-Farahani A. Association of lipid accumulation product with type 2 diabetes mellitus, hypertension, and mortality: a systematic review and meta-analysis. J Diabetes Metab Disord. 2022;21(2):1943\u201373.","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"4353_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3121\/cmr.2020.1509","volume":"18","author":"MA Raposo","year":"2020","unstructured":"Raposo MA, Guimar\u00e3es NS, Tupinamb\u00e1s U. Lipid accumulation product index to predict metabolic syndrome in people living with HIV. Clin Med Res. 2020;18(4):120\u20135.","journal-title":"Clin Med Res"},{"issue":"1","key":"4353_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-230X-10-98","volume":"10","author":"G Bedogni","year":"2010","unstructured":"Bedogni G, Kahn HS, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol. 2010;10(1):98.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"4353_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81125-3","volume":"92","author":"BB Kahn","year":"1998","unstructured":"Kahn BB. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell. 1998;92(5):593\u20136.","journal-title":"Cell"},{"issue":"1","key":"4353_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12944-023-01802-6","volume":"22","author":"M Ebrahimi","year":"2023","unstructured":"Ebrahimi M, Seyedi SA, Nabipoorashrafi SA, Rabizadeh S, Sarzaeim M, Yadegar A, Mohammadi F, Bahri RA, Pakravan P, Shafiekhani P. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis. Lipids Health Dis. 2023;22(1):41.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"4353_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2217\/bmm-2023-0725","volume":"18","author":"Q Huang","year":"2024","unstructured":"Huang Q, Tan X, Wu Q, Zhao H, Chen H, Yu X, Wang J, Huang X, Huang Y, Wei J. Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease. Biomark Med. 2024;18(3):123\u201335.","journal-title":"Biomark Med"},{"issue":"7","key":"4353_CR24","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/metabo12070664","volume":"12","author":"AL Han","year":"2022","unstructured":"Han AL, Lee HK. Comparison of the diagnostic performance of steatosis indices for discrimination of CT-diagnosed metabolic dysfunction-associated fatty liver disease. Metabolites. 2022;12(7):664.","journal-title":"Metabolites"},{"issue":"1","key":"4353_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12944-021-01617-3","volume":"21","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang W. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. Lipids Health Dis. 2022;21(1):8.","journal-title":"Lipids Health Dis"},{"issue":"11","key":"4353_CR26","first-page":"750","volume":"17","author":"F Zamani","year":"2014","unstructured":"Zamani F, Sohrabi M, Alipour A, Motamed N, Saeedian FS, Pirzad R, Abedi K, Maadi M, Ajdarkosh H, Hemmasi G, et al. Prevalence and risk factors of cholelithiasis in amol city, Northern iran: a population based study. Arch Iran Med. 2014;17(11):750\u20134.","journal-title":"Arch Iran Med"},{"key":"4353_CR27","doi-asserted-by":"publisher","first-page":"1329380","DOI":"10.3389\/fendo.2024.1329380","volume":"15","author":"N Motamed","year":"2024","unstructured":"Motamed N, Zamani F, Maadi M, Ajdarkosh H, Roozafzai F, Keyvani H, Poustchi H, Shakeri R, Ashrafi GH, Perumal D, et al. A population-based prospective study on obesity-related non-communicable diseases in Northern iran: rationale, study design, and baseline analysis. Front Endocrinol. 2024;15:1329380.","journal-title":"Front Endocrinol"},{"issue":"5","key":"4353_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1017\/S1368980009991698","volume":"13","author":"P Mirmiran","year":"2010","unstructured":"Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654\u201362.","journal-title":"Public Health Nutr"},{"issue":"213","key":"4353_CR29","first-page":"42","volume":"7","author":"M Ghaffarpour","year":"1999","unstructured":"Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran: Nashre Olume Keshavarzy. 1999;7(213):42\u201358.","journal-title":"Tehran: Nashre Olume Keshavarzy"},{"key":"4353_CR30","unstructured":"Nutritionist I. N-squared computing. Silverton: Nutritionist IV. 1998."},{"issue":"7","key":"4353_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"J-H Lee","year":"2010","unstructured":"Lee J-H, Kim D, Kim HJ, Lee C-H, Yang JI, Kim W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"issue":"7","key":"4353_CR32","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/hep4.1935","volume":"6","author":"M Noureddin","year":"2022","unstructured":"Noureddin M, Ntanios F, Malhotra D, Hoover K, Emir B, McLeod E, Alkhouri N. Predicting NAFLD prevalence in the united States using National health and nutrition examination survey 2017\u20132018 transient elastography data and application of machine learning. Hepatol Commun. 2022;6(7):1537\u201348.","journal-title":"Hepatol Commun"},{"issue":"35","key":"4353_CR33","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.3748\/wjg.v27.i35.5803","volume":"27","author":"CG Dietrich","year":"2021","unstructured":"Dietrich CG, Rau M, Geier A. Screening for nonalcoholic fatty liver disease-when, who and how? World J Gastroenterol. 2021;27(35):5803.","journal-title":"World J Gastroenterol"},{"key":"4353_CR34","doi-asserted-by":"publisher","unstructured":"Zhao S, Ren Z, Yu S, Chi C, Tang J, Maimaitiaili R, Teliewubai J, Li J, Xu Y, Zhang Y. Association between lipid accumulation product and target organ damage in elderly population: the Northern Shanghai study. Clin Interv Aging. 2021:2;16:1769\u201376. https:\/\/doi.org\/10.2147\/CIA.S330313.","DOI":"10.2147\/CIA.S330313"},{"issue":"10","key":"4353_CR35","doi-asserted-by":"publisher","first-page":"030006052110499","DOI":"10.1177\/03000605211049960","volume":"49","author":"S Golabi","year":"2021","unstructured":"Golabi S, Ajloo S, Maghsoudi F, Adelipour M, Naghashpour M. Associations between traditional and non-traditional anthropometric indices and cardiometabolic risk factors among inpatients with type 2 diabetes mellitus: a cross-sectional study. J Int Med Res. 2021;49(10):03000605211049960.","journal-title":"J Int Med Res"},{"issue":"4","key":"4353_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1530\/EJE-10-1039","volume":"164","author":"MJ Taverna","year":"2011","unstructured":"Taverna MJ, Mart\u00ednez-Larrad MT, Frechtel GD, Serrano-R\u00edos M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol. 2011;164(4):559\u201367.","journal-title":"Eur J Endocrinol"},{"issue":"S1","key":"4353_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1665-2681(19)31822-8","volume":"8","author":"P Almeda-Vald\u00e9s","year":"2009","unstructured":"Almeda-Vald\u00e9s P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol. 2009;8(S1):18\u201324.","journal-title":"Ann Hepatol"},{"key":"4353_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-021-01613-7","volume":"21","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang W. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. Lipids Health Dis. 2022;21:1\u20139.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"4353_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/EJE-14-0112","volume":"171","author":"DJ Cuthbertson","year":"2014","unstructured":"Cuthbertson DJ, Weickert MO, Lythgoe D, Sprung VS, Dobson R, Shoajee-Moradie F, Umpleby M, Pfeiffer AF, Thomas EL, Bell JD. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. Eur J Endocrinol. 2014;171(5):561\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"4353_CR40","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3889\/oamjms.2018.449","volume":"6","author":"IW Weta","year":"2018","unstructured":"Weta IW, Mahadewa TGB, Sutirtayasa WP, Subawa A, Sitanggang FP, Widyadharma IPE. The comparison of simple anthropometric and biochemical parameters for predicting liver steatosis in obese Balinese young women. Open Access Maced J Med Sci. 2018;6(11):2062.","journal-title":"Open Access Maced J Med Sci"},{"key":"4353_CR41","doi-asserted-by":"publisher","first-page":"1279978","DOI":"10.3389\/fendo.2023.1279978","volume":"14","author":"W Han","year":"2024","unstructured":"Han W, Zhang M, Wang H, Yang Y, Wang L. Lipid accumulation product is an effective predictor of metabolic syndrome in non-obese women with polycystic ovary syndrome. Front Endocrinol. 2024;14:1279978.","journal-title":"Front Endocrinol"},{"issue":"7","key":"4353_CR42","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/humrep\/dep072","volume":"24","author":"D Wiltgen","year":"2009","unstructured":"Wiltgen D, Benedetto I, Mastella L, Spritzer P. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod. 2009;24(7):1726\u201331.","journal-title":"Hum Reprod"},{"issue":"10","key":"4353_CR43","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.3748\/wjg.v22.i10.3023","volume":"22","author":"N Motamed","year":"2016","unstructured":"Motamed N, Sohrabi M, Ajdarkosh H, Hemmasi G, Maadi M, Sayeedian FS, Pirzad R, Abedi K, Aghapour S, Fallahnezhad M. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol. 2016;22(10):3023.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4353_CR44","volume":"2019","author":"S Tantanavipas","year":"2019","unstructured":"Tantanavipas S, Vallibhakara O, Sobhonslidsuk A, Phongkitkarun S, Vallibhakara SA-O, Promson K, et al. Abdominal obesity as a predictive factor of nonalcoholic fatty liver disease assessed by ultrasonography and transient elastography in polycystic ovary syndrome and healthy women. Biomed Res Int. 2019;2019(1):9047324.","journal-title":"Biomed Res Int"},{"issue":"2","key":"4353_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cld.2015.10.007","volume":"20","author":"PD Berk","year":"2016","unstructured":"Berk PD, Verna EC. Nonalcoholic fatty liver disease: lipids and insulin resistance. Clin Liver Dis. 2016;20(2):245\u201362.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"4353_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020622","volume":"13","author":"VJ Antraco","year":"2021","unstructured":"Antraco VJ, Hirata BKS, de Jesus Simao J, Cruz MM, da Silva VS, da Cunha Sa RDC, et al. Omega-3 polyunsaturated fatty acids prevent nonalcoholic steatohepatitis (NASH) and stimulate adipogenesis. Nutrients. 2021;13(2):622.","journal-title":"Nutrients"},{"issue":"2","key":"4353_CR47","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5152\/tjg.2020.18594","volume":"31","author":"B Pirimo\u011flu","year":"2020","unstructured":"Pirimo\u011flu B, Sade R, Polat G, \u0130\u015flek A, Kantarc\u0131 M. Analysis of correlation between liver fat fraction and AST and ALT levels in overweight and obese children by using new magnetic resonance imaging technique. Turk J Gastroenterol. 2020;31(2):156.","journal-title":"Turk J Gastroenterol"},{"issue":"6","key":"4353_CR48","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1053\/j.gastro.2008.09.018","volume":"135","author":"W Goessling","year":"2008","unstructured":"Goessling W, Massaro JM, Vasan RS, D\u2019Agostino Sr RB, Ellison RC, Fox CS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology. 2008;135(6):1935\u201344. e1931.","journal-title":"Gastroenterology"},{"issue":"4","key":"4353_CR49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.15403\/jgld-293","volume":"28","author":"C Ulasoglu","year":"2019","unstructured":"Ulasoglu C, Enc FY, Kaya E, Yilmaz Y. Characterization of patients with biopsy-proven non-alcoholic fatty liver disease and normal aminotransferase levels. J Gastrointestin Liver Dis. 2019;28(4):427\u201331.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"15","key":"4353_CR50","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3748\/wjg.15.1863","volume":"15","author":"HS Uslusoy","year":"2009","unstructured":"Uslusoy HS, Nak SG, G\u00fclten M, B\u0131y\u0131kl\u0131 Z. Non-alcoholic steatohepatitis with normal aminotransferase values. World J Gastroenterology: WJG. 2009;15(15):1863.","journal-title":"World J Gastroenterology: WJG"},{"issue":"6","key":"4353_CR51","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","volume":"37","author":"P Mofrad","year":"2003","unstructured":"Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37(6):1286\u201392.","journal-title":"Hepatology"},{"issue":"3","key":"4353_CR52","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48(3):792\u20138.","journal-title":"Hepatology"},{"issue":"11","key":"4353_CR53","first-page":"709","volume":"96","author":"RC Oh","year":"2017","unstructured":"Oh RC, Hustead TR, Ali SM, Pantsari MW. Mildly elevated liver transaminase levels: causes and evaluation. Am Fam Physician. 2017;96(11):709\u201315.","journal-title":"Am Fam Physician"},{"issue":"3","key":"4353_CR54","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/MOL.0b013e3283613a94","volume":"24","author":"M Barton","year":"2013","unstructured":"Barton M. Cholesterol and atherosclerosis: modulation by oestrogen. Curr Opin Lipidol. 2013;24(3):214\u201320.","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"4353_CR55","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1210\/jc.2003-030242","volume":"88","author":"MC Carr","year":"2003","unstructured":"Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4353_CR56","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ijo.2008.25","volume":"32","author":"JC Lovejoy","year":"2008","unstructured":"Lovejoy JC, Champagne C, De Jonge L, Xie H, Smith S. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32(6):949\u201358.","journal-title":"Int J Obes"},{"issue":"9","key":"4353_CR57","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/met.2018.0019","volume":"16","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Jo HN, Kim YH, Kim SC, Joo JK, Lee KS. Predictive value of lipid accumulation product, fatty liver index, visceral adiposity index for metabolic syndrome according to menopausal status. Metab Syndr Relat Disord. 2018;16(9):477\u201382.","journal-title":"Metab Syndr Relat Disord"},{"issue":"10","key":"4353_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002258","volume":"4","author":"L Hodson","year":"2015","unstructured":"Hodson L, Banerjee R, Rial B, Arlt W, Adiels M, Boren J, et al. Menopausal status and abdominal obesity are significant determinants of hepatic lipid metabolism in women. J Am Heart Assoc. 2015;4(10):e002258.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"4353_CR59","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1080\/09513590.2016.1214257","volume":"32","author":"O Taleb-Belkadi","year":"2016","unstructured":"Taleb-Belkadi O, Chaib H, Zemour L, Fatah A, Chafi B, Mekki K. Lipid profile, inflammation, and oxidative status in peri- and postmenopausal women. Gynecol Endocrinol. 2016;32(12):982\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"4353_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12986-017-0206-2","volume":"14","author":"H Dai","year":"2017","unstructured":"Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab. 2017;14(1):49.","journal-title":"Nutr Metab"},{"key":"4353_CR61","doi-asserted-by":"crossref","unstructured":"Li H, Zhang Y, Luo H, Lin R. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the united States adults. Front Endocrinol 2022, Volume 13\u20132022.","DOI":"10.3389\/fendo.2022.977625"},{"issue":"12","key":"4353_CR62","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3345\/kjp.2019.00248","volume":"62","author":"B \u00d6zcab\u0131","year":"2019","unstructured":"\u00d6zcab\u0131 B, Demirhan S, Akyol M, \u00d6zt\u00fcrkmen Akay H, G\u00fcven A. Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity. Korean J Pediatr. 2019;62(12):450\u20135.","journal-title":"Korean J Pediatr"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04353-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04353-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04353-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:02:56Z","timestamp":1767110576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04353-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4353"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04353-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the declaration of Helsinki and was approved by the Ethics Committee of Iran University of Medical Sciences. All participants read and signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"889"}}